Equillium (EQ) Acquisitions (2022)

Equillium's (EQ) quarterly Acquisitions came in at $700000.0 in Q1 2022.

Equillium (EQ) Acquisitions (2022) Analysis & Trends

Equillium (EQ) has 1 years of Acquisitions data on file, last reported at $700000.0 in Q1 2022.

On a quarterly basis, Acquisitions changed N/A year-over-year to $700000.0 in Q1 2022; TTM through Dec 2022 was $700000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $700000.0, changed N/A from the prior year.
Acquisitions for Q1 2022 stood at $700000.0.
Over the last five years, Acquisitions for EQ reached as high as $700000.0 in Q1 2022 and fell as low as $700000.0 in Q1 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Equillium	242.14 Mn	242.14 Mn	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2022	700,000.00